Gufic Biosciences has targeted to capture major share of Rs. 3000 crore lyophilized antibacterial market in India. Gufic has launched New Drug Delivery System: Dual Chamber Bags at affordable price for the first time in India. Contributing immensely to the governments ambitious Make in India drive, Gufic has collaborated with its European counterpart to manufacture this new technology indigenously in India. Until now the dual […]
Arvind has allotted 2,50,000 equity shares of Rs 10 each under ESOP on 06 June 2022. Powered by Capital Market – Live News
Share India Securities announced that the Acuit? Ratings & Research (?Credit Rating Agency?) has assigned its credit rating for Non Convertible Debentures of the Company aggregating Rs 150 crore at ACUITE PP-MLD A; Stable.Powered by Capital Market – Live News
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
